Download PDF
Semin Reprod Med 2014; 32(03): 177-182
DOI: 10.1055/s-0034-1371089
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Genetics of Polycystic Ovary Syndrome

Corrine K. Welt
1   Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts
,
Jessica M. Duran
1   Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts
2   Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
08 April 2014 (online)

    Permissions and Reprints

Abstract

The etiology of polycystic ovary syndrome (PCOS) has been difficult to determine because its features are heterogeneous, and its origin may also be heterogeneous. Twin studies suggest that its etiology is strongly heritable and genetic approaches are rapidly uncovering new regions of the genome that appear to confer risk for PCOS. Recent genome-wide association studies in Han Chinese women with PCOS demonstrate 11 genetic loci that are associated with PCOS. The variants identified are in regions that contain genes important for gonadotropin action, genes that are associated with risk for type 2 diabetes, and other genes in which the relationship to PCOS is not yet clear. Replication studies have demonstrated that variants at several of these loci also confer risk for PCOS in women of European ethnicity. The strongest loci in Europeans contain genes for DENND1A and THADA, with additional associations in loci containing the LHCGR and FSHR, YAP1 and RAB5/SUOX. The next steps in uncovering the pathophysiology borne out by these loci and variants will include mapping to determine the causal variant and gene, phenotype studies to determine whether these regions are associated with particular features of PCOS and functional studies of the causal variant to determine the direct cause of PCOS based on the underlying genetics. The next years will be very exciting times as groups from around the world come together to further elucidate the genetic origins of PCOS.

Keywords

genome-wide association - gonadotropins - hyperandrogenism
 

  • References

  • 1 Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83 (9) 3078-3082
    CrossrefPubMedGoogle Scholar
  • 2 Diamanti-Kandarakis E, Kouli CR, Bergiele AT , et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84 (11) 4006-4011
    CrossrefPubMedGoogle Scholar
  • 3 Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85 (7) 2434-2438
    CrossrefPubMedGoogle Scholar
  • 4 Taylor AE, McCourt B, Martin KA , et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82 (7) 2248-2256
    CrossrefPubMedGoogle Scholar
  • 5 Rebar R, Judd HL, Yen SSC, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 1976; 57 (5) 1320-1329
    CrossrefPubMedGoogle Scholar
  • 6 Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley Jr WF. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988; 66 (1) 165-172
    CrossrefPubMedGoogle Scholar
  • 7 Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1983; 57 (2) 356-359
    CrossrefPubMedGoogle Scholar
  • 8 Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38 (9) 1165-1174
    CrossrefPubMedGoogle Scholar
  • 9 Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191
    PubMedGoogle Scholar
  • 10 Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986; 293 (6543) 355-359
    CrossrefPubMedGoogle Scholar
  • 11 Pigny P, Merlen E, Robert Y , et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003; 88 (12) 5957-5962
    CrossrefPubMedGoogle Scholar
  • 12 Adams JM, Taylor AE, Crowley Jr WF, Hall JE. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 2004; 89 (9) 4343-4350
    CrossrefPubMedGoogle Scholar
  • 13 Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 2005; 90 (5) 2571-2579
    CrossrefPubMedGoogle Scholar
  • 14 Welt CK, Arason G, Gudmundsson JA , et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab 2006; 91 (11) 4361-4368
    CrossrefPubMedGoogle Scholar
  • 15 National Institutes of Health. Evidence-Based Methodology Workshop on Polycystic Ovary Syndrome: Executive Summary. Washington: National Institutes of Health: 2013. Available at: prevention nih gov/workshops/2012/pcos/docs/PCOS_Final_Statement pdf. Accessed on October 1, 2013
    PubMedGoogle Scholar
  • 16 Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) 2005; 62 (3) 289-295
    CrossrefPubMedGoogle Scholar
  • 17 Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 2006; 91 (6) 2100-2104
    CrossrefPubMedGoogle Scholar
  • 18 Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59 (5) 983-989
    PubMedGoogle Scholar
  • 19 Altshuler D, Hirschhorn JN, Klannemark M , et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26 (1) 76-80
    CrossrefPubMedGoogle Scholar
  • 20 Pau C, Saxena R, Welt CK. Evaluating reported candidate gene associations with polycystic ovary syndrome. Fertil Steril 2013; 99 (6) 1774-1778
    CrossrefPubMedGoogle Scholar
  • 21 Ewens KG, Stewart DR, Ankener W , et al. Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab 2010; 95 (5) 2306-2315
    CrossrefPubMedGoogle Scholar
  • 22 Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007; 3 (2) 103-111
    CrossrefPubMedGoogle Scholar
  • 23 Lander ES, Linton LM, Birren B , et al; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409 (6822) 860-921
    CrossrefPubMedGoogle Scholar
  • 24 International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437 (7063) 1299-1320
    CrossrefPubMedGoogle Scholar
  • 25 Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6 (2) 95-108
    PubMedGoogle Scholar
  • 26 Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005; 6 (2) 109-118
    CrossrefPubMedGoogle Scholar
  • 27 Chen ZJ, Zhao H, He L , et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011; 43 (1) 55-59
    CrossrefPubMedGoogle Scholar
  • 28 Shi Y, Zhao H, Shi Y , et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 2012; 44 (9) 1020-1025
    CrossrefPubMedGoogle Scholar
  • 29 Goodarzi MO, Jones MR, Li X , et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet 2012; 49 (2) 90-95
    CrossrefPubMedGoogle Scholar
  • 30 Lerchbaum E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B. Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women. Horm Metab Res 2011; 43 (11) 743-747
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Welt CK, Styrkarsdottir U, Ehrmann DA , et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab Res 2012; 97 (7) E1342-E1347
    PubMedGoogle Scholar
  • 32 Louwers YV, Stolk L, Uitterlinden AG. Replication of Chinese PCOS susceptibility loci in patients diagnosed with PCOS from Caucasian descent. Poster presented at: 95th Annual Meeting of the Endocrine Society; June 15–18, 2013; San Francisco, CA. Poster MON-549
    PubMedGoogle Scholar
  • 33 Marat AL, Dokainish H, McPherson PS. DENN domain proteins: regulators of Rab GTPases. J Biol Chem 2011; 286 (16) 13791-13800
    CrossrefPubMedGoogle Scholar
  • 34 Tasaka K, Masumoto N, Mizuki J , et al. Rab3B is essential for GnRH-induced gonadotrophin release from anterior pituitary cells. J Endocrinol 1998; 157 (2) 267-274
    CrossrefPubMedGoogle Scholar
  • 35 Zeggini E, Scott LJ, Saxena R , et al; Wellcome Trust Case Control Consortium. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40 (5) 638-645
    CrossrefPubMedGoogle Scholar
  • 36 Mutharasan P, Galdones E, Peñalver Bernabé B , et al. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab 2013; 98 (1) E185-E190
    CrossrefPubMedGoogle Scholar
  • 37 Kawamura K, Cheng Y, Suzuki N , et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment [published ahead of print September 30, 2013]. PNAS . doi:10.1073/pnas.1312830110
    PubMedGoogle Scholar
  • 38 Wang H, Jin Y, Reddy MV , et al. Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk. PLoS ONE 2010; 5 (7) e11789
    CrossrefPubMedGoogle Scholar
  • 39 McCarthy MI, Hirschhorn JN. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 2008; 17 (R2): R156-R165
    CrossrefPubMedGoogle Scholar
  • 40 Todd JA. Statistical false positive or true disease pathway?. Nat Genet 2006; 38 (7) 731-733
    CrossrefPubMedGoogle Scholar
  • 41 Tsao H, Florez JC. Introduction to genetic association studies. J Invest Dermatol 2007; 127 (10) 2283-2287
    CrossrefPubMedGoogle Scholar
  • 42 Cui L, Zhao H, Zhang B , et al. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum Reprod 2013; 28 (2) 538-544
    CrossrefPubMedGoogle Scholar
  • 43 Strauss III JF, McAllister JM, Urbanek M. Persistence pays off for PCOS gene prospectors. J Clin Endocrinol Metab 2012; 97 (7) 2286-2288
    CrossrefPubMedGoogle Scholar
  • 44 Saxena R, Welt CK. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetol 2013; 50 (3) 451-457
    CrossrefPubMedGoogle Scholar
  • 45 Ewens KG, Jones MR, Ankener W , et al. Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril 2011; 95 (8) 2538-2541 , e1–e6
    CrossrefPubMedGoogle Scholar
  • 46 Biyasheva A, Legro RS, Dunaif A, Urbanek M. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab 2009; 94 (7) 2617-2625
    CrossrefPubMedGoogle Scholar
  • 47 Voight BF, Scott LJ, Steinthorsdottir V , et al; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010; 42 (7) 579-589
    CrossrefPubMedGoogle Scholar
  • 48 Lyssenko V, Lupi R, Marchetti P , et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117 (8) 2155-2163
    CrossrefPubMedGoogle Scholar
  • 49 Frayling TM, Timpson NJ, Weedon MN , et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316 (5826) 889-894
    CrossrefPubMedGoogle Scholar
  • 50 Ewens KG, Jones MR, Ankener W , et al. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS ONE 2011; 6 (1) e16390
    CrossrefPubMedGoogle Scholar
  • 51 Barber TM, Bennett AJ, Groves CJ , et al. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia 2008; 51 (7) 1153-1158
    CrossrefPubMedGoogle Scholar
  • 52 Li T, Wu K, You L , et al. Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome. PLoS ONE 2013; 8 (7) e66250
    CrossrefPubMedGoogle Scholar